Zubair Khalid

Virologist/Molecular Biologist | Veterinarian | Bioinformatician

Conventional & Molecular Virology • Vaccine Development • Computational Biology

Dr. Zubair Khalid is a veterinarian and virologist specializing in conventional and molecular virology, vaccine development, and computational biology. Dedicated to advancing animal health through innovative research and multi-omics approaches.

Dr. Zubair Khalid - Veterinarian, Virologist, and Vaccine Development Researcher specializing in Computational Biology, Multi-omics, Animal Health, and Infectious Disease Research

Blog · Guides · Published 2026-07-12

Differential Splicing Analysis: Designing a Careful RNA Seq Study

If you plan to study alternative splicing using RNA sequencing, you need to understand that differential splicing analysis is fundamentally different from differential gene expression. This guide explains the critical decisions around annotation dependence, sequencing depth, event definitions, validation, and the inherent limits of transcript level inference. It is intended for researchers who have experience with standard RNA seq differential expression and now want to investigate splicing changes. You should use this guide as a companion when designing your study, before you generate data or run any software. A thoughtful plan prevents many analytical pitfalls later. As the EMBL EBI Training resources note, splicing analysis introduces layers of complexity that are often underestimated. The core challenge is that splicing events are not directly observed but inferred from short reads, and every inference depends heavily on the reference annotation you choose.

At a Glance

Consideration Key Question Impact
Annotation dependence Does your annotation match your sample’s biology? Missed or false events
Read depth Do you have enough coverage for isoform ratios? Low power for rare splice variants
Event definition Will you analyse exon usage, splice junctions, or full transcripts? Different tools and statistical power
Validation How will you confirm candidate events? False discovery rate control
Transcript level inference Can you accurately quantify full length isoforms? Very limited for most short read data

Understanding Annotation Dependence

Most differential splicing tools rely on a gene annotation to define splice junctions, exons, and transcript structures. If your organism’s annotation is incomplete or if your sample expresses tissue specific isoforms that are not in the reference, you will miss those events entirely. The NCBI Bookshelf provides authoritative background on how annotations are built, but even the best human annotation (GENCODE) does not cover all context dependent splicing. For non model organisms the problem is more severe. Always check whether your annotation includes the cell types, developmental stages, or conditions you are studying. A bovine study described in the Cattle BodyMap transcriptome paper mapped splicing patterns across 52 tissues and three developmental stages, discovering thousands of new splice junctions not present in the original annotation. This illustrates that annotation dependence is not a minor detail, it determines the sensitivity of your entire analysis. Consider using annotation free or de novo approaches to supplement your analysis, but be aware that these come with their own high false positive rates.

Read Depth and Power for Splicing

Standard RNA seq experiments for differential expression typically aim for 20 30 million reads per sample. For splicing analysis you often need more, sometimes two to four times as many reads, because splicing events are quantified from junction reads or local coverage changes. Rare exon inclusion events require deep sequencing to achieve adequate statistical power. A study on immune regulation using single cell genomics emphasised that even in bulk RNA seq, low coverage exons can be entirely missed in differential splicing tests. As a rule of thumb, for a well annotated transcriptome you should plan for at least 40 60 million paired end reads per sample if you are interested in moderate splicing changes. For discovery of novel splice variants, 100 million or more may be needed. The Galaxy Training Network offers practical workflows that include read depth diagnostics, such as counting reads supporting each junction, to help you assess whether your data are sufficient.

Defining Splicing Events: Exon vs. Transcript Level

There is no single best way to define a splicing event. The three most common approaches are exon centric, junction centric, and transcript level analysis. Exon centric methods (e.g., DEXSeq) test whether a specific exon is included or skipped relative to other exons in the same gene. Junction centric methods (e.g., rMATS) count reads that span specific splice junctions and test for differential usage. Transcript level methods (e.g., Salmon + tximport + DRIMSeq) attempt to quantify full length isoforms and test for changes in isoform proportions.

Each approach has trade offs. Exon and junction methods are more robust to annotation errors and require less read depth, but they do not capture complex splicing patterns involving multiple exons. Transcript level methods promise a more complete picture, but they are highly sensitive to annotation completeness and read length. In practice, most published studies use a combination, as shown in the DRIVE resource that deciphered drug induced splicing responses. They ran both junction based and exon based analyses to cross validate findings. You should decide on your primary event definition before analysis, and always report which type you used. Avoid mixing results from different definitions without adjustment.

Validation Strategies

Differential splicing calls have high false positive rates, especially for events supported by few reads or for novel junctions. Validation can be performed using RT PCR, long read sequencing, or targeted capture. For high throughput validation, orthogonal short read data from a different library preparation can help, but the best approach is to use long read sequencing, which directly sequences full length cDNA. A practical example comes from the work on chimeric RNA detection where authors used FusionBlaster to quantify chimeric transcripts and then validated with targeted long reads. For standard splicing events, you can also check reproducibility across biological replicates. The Bioconductor project includes packages like stageR that control the false discovery rate at the gene level before testing individual events. Always plan a validation subset in your budget, aiming to test at least 10 20 candidate events. Without validation, your splicing analysis remains exploratory.

Limits of Transcript Level Inference

The most common mistake in differential splicing analysis is to assume that short read RNA seq can accurately quantify full length transcript isoforms. It cannot. Short reads usually span only one or two exons, so they do not contain enough information to resolve combinatorial isoform usage. As a result, transcript level estimates are highly uncertain and often unreliable for genes with many isoforms. The study on GLS mediated cuproptosis in ovarian cancer used long read sequencing to confirm isoform changes that were only weakly suggested by short read data. If you need to report which specific transcript isoforms are differentially used, you must use long read sequencing or carefully limit your claims to well separated isoforms with unique exon combinations. For most RNA seq experiments, the safest approach is to report differential exon usage or differential junction usage, not differential transcript usage. This limitation is well documented in the NCBI Sequence Read Archive documentation and in multiple benchmarking studies. Do not over interpret transcript level results from standard RNA seq.

Practical Workflow for Differential Splicing Analysis

Follow these steps to design and execute a careful study.

  1. Define your splicing question. Decide whether you will test for differential exon inclusion, differential junction usage, or differential isoform proportions. This choice determines your required read depth and analysis tool.

  2. Choose an annotation. Download the most comprehensive annotation for your organism and conditions. Consider supplementing with tissue specific annotations from public resources like the EMBL EBI Training materials on reference genomes.

  3. Estimate required sequencing depth. Use pilot data or published guidelines to set a target of at least 40 million paired end reads per sample for exon level analysis. Increase for transcript level analysis.

  4. Preprocess reads. Perform quality control and trimming. The Galaxy Training Network provides step by step tutorials for read preprocessing tailored to splicing analysis.

  5. Align or pseudoalign. Use a splice aware aligner (STAR, HISAT2) or a lightweight quantification tool (Salmon, kallisto). The alignment step is critical for junction detection.

  6. Quantify events. Run your chosen tool (e.g., rMATS for junctions, DEXSeq for exons, DRIMSeq for transcripts). Ensure you provide the same annotation used in step 2.

  7. Filter and test. Remove events with low counts. Use a gene level error control if testing many events per gene. The Bioconductor package stageR helps with this.

  8. Validate. Select top candidates for RT PCR or long read sequencing. Cross check with an independent method if possible.

  9. Report results clearly. List the event type, genomic coordinates, read support, and p values. Avoid strong statements about isoform switches without long read confirmation.

Common Mistakes

  • Using an inappropriate annotation, such as a general reference when studying a specific tissue with known unusual splicing (e.g., brain or testis).
  • Assuming that all differentially expressed transcripts are also differentially spliced. Splicing analysis must normalize for overall gene expression.
  • Overlooking batch effects that can mimic splicing changes, especially when samples are sequenced in different batches. The NCBI Bookshelf discusses batch correction, but it is harder for splicing than for expression.
  • Interpreting transcript level quantifications as if they were measured directly. Always state the inference process in your methods.
  • Ignoring multi mapping reads. Many splice junction reads map to multiple genes, especially in paralogous families. Filter or handle these with care.
  • Using default parameters without checking whether they are appropriate for your read length and library type.

Frequently Asked Questions

What is the minimum read depth for differential splicing analysis?

For exon level tests with a well annotated genome, 40 million paired end reads per sample is a safe minimum. For junction level analysis you may need 60 million. For transcript level analysis, 100 million or more is common, but even then many isoforms remain poorly quantified. Check your data with diagnostic plots after alignment.

Can I use standard differential expression tools for splicing?

No. Standard tools (e.g., DESeq2, edgeR) are designed for gene level or transcript level counts, but they do not model the correlation between exons within a gene. Using them to test each exon separately inflates false positives. Use dedicated splicing tools that account for the relative nature of splicing events.

Do I need biological replicates for splicing analysis?

Yes. Splicing is highly variable between individuals. At least three replicates per condition is strongly recommended. Pooling replicates without testing for consistency can lead to false discoveries. The resource on drug induced splicing used multiple replicates to filter reproducible events.

How do I know if my splicing event is real without validation?

You cannot be completely sure. Statistical significance alone is not sufficient due to high false discovery rates from multiple testing and alignment errors. Reproducibility across replicates and independent cohorts increases confidence but does not replace experimental validation. Always report validation status in your publication.

References and Further Reading

Related Articles